nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A5—prostate cancer	0.2	0.698	CbGaD
Triazolam—CYP3A4—prostate cancer	0.0865	0.302	CbGaD
Triazolam—CYP2C8—Nilutamide—prostate cancer	0.0316	0.0709	CbGbCtD
Triazolam—CYP3A5—Flutamide—prostate cancer	0.0272	0.0611	CbGbCtD
Triazolam—CYP2C8—Abiraterone—prostate cancer	0.0262	0.0588	CbGbCtD
Triazolam—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0244	0.0548	CbGbCtD
Triazolam—CYP2C9—Bicalutamide—prostate cancer	0.022	0.0495	CbGbCtD
Triazolam—CYP2C9—Nilutamide—prostate cancer	0.022	0.0495	CbGbCtD
Triazolam—CYP3A5—Cabazitaxel—prostate cancer	0.0201	0.0452	CbGbCtD
Triazolam—CYP3A5—Estrone—prostate cancer	0.0197	0.0442	CbGbCtD
Triazolam—CYP2C8—Cabazitaxel—prostate cancer	0.0193	0.0435	CbGbCtD
Triazolam—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0169	0.0379	CbGbCtD
Triazolam—CYP3A7—Estradiol—prostate cancer	0.0151	0.0338	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.0151	0.0338	CbGbCtD
Triazolam—CYP2C9—Estrone—prostate cancer	0.0132	0.0296	CbGbCtD
Triazolam—CYP3A4—Bicalutamide—prostate cancer	0.0128	0.0288	CbGbCtD
Triazolam—CYP3A4—Estramustine—prostate cancer	0.0119	0.0267	CbGbCtD
Triazolam—CYP3A5—Estradiol—prostate cancer	0.0113	0.0254	CbGbCtD
Triazolam—CYP2C8—Estradiol—prostate cancer	0.0109	0.0244	CbGbCtD
Triazolam—CYP3A4—Flutamide—prostate cancer	0.0106	0.0238	CbGbCtD
Triazolam—CYP3A4—Abiraterone—prostate cancer	0.0106	0.0238	CbGbCtD
Triazolam—CYP2C9—Capecitabine—prostate cancer	0.00999	0.0225	CbGbCtD
Triazolam—CYP3A7—Docetaxel—prostate cancer	0.00899	0.0202	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00899	0.0202	CbGbCtD
Triazolam—CYP3A4—Cabazitaxel—prostate cancer	0.00785	0.0176	CbGbCtD
Triazolam—CYP3A4—Estrone—prostate cancer	0.00767	0.0172	CbGbCtD
Triazolam—CYP2C9—Estradiol—prostate cancer	0.00757	0.017	CbGbCtD
Triazolam—CYP3A5—Etoposide—prostate cancer	0.00737	0.0166	CbGbCtD
Triazolam—CYP2C8—Etoposide—prostate cancer	0.00709	0.0159	CbGbCtD
Triazolam—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00683	0.0154	CbGbCtD
Triazolam—CYP3A5—Docetaxel—prostate cancer	0.00675	0.0152	CbGbCtD
Triazolam—CYP3A4—Conjugated Estrogens—prostate cancer	0.00502	0.0113	CbGbCtD
Triazolam—CYP3A4—Mitoxantrone—prostate cancer	0.00456	0.0102	CbGbCtD
Triazolam—CYP3A4—Estradiol—prostate cancer	0.0044	0.0099	CbGbCtD
Triazolam—CYP3A4—Prednisone—prostate cancer	0.00379	0.00851	CbGbCtD
Triazolam—CYP3A4—Etoposide—prostate cancer	0.00288	0.00646	CbGbCtD
Triazolam—CYP3A4—Docetaxel—prostate cancer	0.00263	0.00591	CbGbCtD
Triazolam—CYP3A4—Doxorubicin—prostate cancer	0.00196	0.00441	CbGbCtD
Triazolam—CYP2C9—urine—prostate cancer	0.00111	0.0745	CbGeAlD
Triazolam—GABRP—prostate gland—prostate cancer	0.000918	0.0615	CbGeAlD
Triazolam—CYP3A4—urine—prostate cancer	0.000847	0.0568	CbGeAlD
Triazolam—Lorazepam—UGT2B15—prostate cancer	0.000765	0.168	CrCbGaD
Triazolam—GABRE—prostate gland—prostate cancer	0.000701	0.047	CbGeAlD
Triazolam—TSPO—prostate gland—prostate cancer	0.000654	0.0439	CbGeAlD
Triazolam—GABRP—urethra—prostate cancer	0.000615	0.0412	CbGeAlD
Triazolam—GABRB3—prostate gland—prostate cancer	0.000594	0.0398	CbGeAlD
Triazolam—GABRE—seminal vesicle—prostate cancer	0.000593	0.0397	CbGeAlD
Triazolam—GABRG3—testis—prostate cancer	0.000584	0.0391	CbGeAlD
Triazolam—GABRR1—testis—prostate cancer	0.000557	0.0373	CbGeAlD
Triazolam—TSPO—seminal vesicle—prostate cancer	0.000553	0.0371	CbGeAlD
Triazolam—GABRD—testis—prostate cancer	0.000484	0.0324	CbGeAlD
Triazolam—TSPO—epithelium—prostate cancer	0.000481	0.0322	CbGeAlD
Triazolam—GABRE—urethra—prostate cancer	0.000469	0.0314	CbGeAlD
Triazolam—GABRA5—testis—prostate cancer	0.000449	0.0301	CbGeAlD
Triazolam—TSPO—renal system—prostate cancer	0.000446	0.0299	CbGeAlD
Triazolam—TSPO—urethra—prostate cancer	0.000438	0.0294	CbGeAlD
Triazolam—GABRR2—lymph node—prostate cancer	0.000419	0.0281	CbGeAlD
Triazolam—GABRA3—testis—prostate cancer	0.000418	0.028	CbGeAlD
Triazolam—CYP3A5—prostate gland—prostate cancer	0.000405	0.0272	CbGeAlD
Triazolam—Oxazepam—UGT2B15—prostate cancer	0.000401	0.0883	CrCbGaD
Triazolam—Oxazepam—CYP3A43—prostate cancer	0.000348	0.0765	CrCbGaD
Triazolam—GABRB2—testis—prostate cancer	0.000341	0.0228	CbGeAlD
Triazolam—TSPO—bone marrow—prostate cancer	0.000337	0.0226	CbGeAlD
Triazolam—Clonazepam—NAT2—prostate cancer	0.000334	0.0735	CrCbGaD
Triazolam—GABRE—testis—prostate cancer	0.000309	0.0207	CbGeAlD
Triazolam—CYP2C8—renal system—prostate cancer	0.000306	0.0205	CbGeAlD
Triazolam—TSPO—testis—prostate cancer	0.000288	0.0193	CbGeAlD
Triazolam—CYP3A5—renal system—prostate cancer	0.000276	0.0185	CbGeAlD
Triazolam—GABRB3—testis—prostate cancer	0.000262	0.0175	CbGeAlD
Triazolam—GABRA2—lymph node—prostate cancer	0.000226	0.0151	CbGeAlD
Triazolam—GABRE—lymph node—prostate cancer	0.000224	0.015	CbGeAlD
Triazolam—TSPO—lymph node—prostate cancer	0.000209	0.014	CbGeAlD
Triazolam—CYP3A4—renal system—prostate cancer	0.000207	0.0139	CbGeAlD
Triazolam—CYP2C8—testis—prostate cancer	0.000198	0.0133	CbGeAlD
Triazolam—Clotiazepam—CYP2C18—prostate cancer	0.000197	0.0433	CrCbGaD
Triazolam—Clobazam—CYP2C18—prostate cancer	0.000186	0.0409	CrCbGaD
Triazolam—Alprazolam—CYP3A5—prostate cancer	0.000122	0.027	CrCbGaD
Triazolam—Diazepam—CYP2C18—prostate cancer	0.000109	0.0239	CrCbGaD
Triazolam—Flunitrazepam—CYP2A6—prostate cancer	0.000109	0.0239	CrCbGaD
Triazolam—Muscular weakness—Epirubicin—prostate cancer	0.000107	0.000686	CcSEcCtD
Triazolam—Hallucination—Prednisone—prostate cancer	0.000107	0.000685	CcSEcCtD
Triazolam—Mood swings—Doxorubicin—prostate cancer	0.000106	0.000682	CcSEcCtD
Triazolam—Dysgeusia—Docetaxel—prostate cancer	0.000106	0.000681	CcSEcCtD
Triazolam—Ataxia—Doxorubicin—prostate cancer	0.000106	0.000677	CcSEcCtD
Triazolam—Feeling abnormal—Mitoxantrone—prostate cancer	0.000105	0.000676	CcSEcCtD
Triazolam—Erythema—Capecitabine—prostate cancer	0.000105	0.000673	CcSEcCtD
Triazolam—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000105	0.000671	CcSEcCtD
Triazolam—Muscle spasms—Docetaxel—prostate cancer	0.000104	0.000668	CcSEcCtD
Triazolam—Tachycardia—Etoposide—prostate cancer	0.000104	0.000666	CcSEcCtD
Triazolam—Flatulence—Capecitabine—prostate cancer	0.000103	0.000663	CcSEcCtD
Triazolam—Midazolam—SLC22A1—prostate cancer	0.000103	0.0228	CrCbGaD
Triazolam—Nausea—Goserelin—prostate cancer	0.000103	0.00066	CcSEcCtD
Triazolam—Hyperhidrosis—Etoposide—prostate cancer	0.000103	0.00066	CcSEcCtD
Triazolam—Dysgeusia—Capecitabine—prostate cancer	0.000103	0.000659	CcSEcCtD
Triazolam—Nausea—Conjugated Estrogens—prostate cancer	0.000102	0.000654	CcSEcCtD
Triazolam—Anorexia—Etoposide—prostate cancer	0.000101	0.000651	CcSEcCtD
Triazolam—Hypersensitivity—Estradiol—prostate cancer	0.000101	0.000649	CcSEcCtD
Triazolam—Abdominal pain—Mitoxantrone—prostate cancer	0.000101	0.000649	CcSEcCtD
Triazolam—Muscle spasms—Capecitabine—prostate cancer	0.000101	0.000647	CcSEcCtD
Triazolam—Muscular weakness—Doxorubicin—prostate cancer	9.91e-05	0.000635	CcSEcCtD
Triazolam—Asthenia—Estradiol—prostate cancer	9.86e-05	0.000632	CcSEcCtD
Triazolam—Tremor—Capecitabine—prostate cancer	9.83e-05	0.00063	CcSEcCtD
Triazolam—Dysuria—Epirubicin—prostate cancer	9.81e-05	0.000629	CcSEcCtD
Triazolam—Ill-defined disorder—Capecitabine—prostate cancer	9.74e-05	0.000624	CcSEcCtD
Triazolam—Syncope—Docetaxel—prostate cancer	9.72e-05	0.000623	CcSEcCtD
Triazolam—Pruritus—Estradiol—prostate cancer	9.72e-05	0.000623	CcSEcCtD
Triazolam—Clonazepam—CYP2E1—prostate cancer	9.6e-05	0.0211	CrCbGaD
Triazolam—Palpitations—Docetaxel—prostate cancer	9.58e-05	0.000614	CcSEcCtD
Triazolam—Paraesthesia—Etoposide—prostate cancer	9.56e-05	0.000613	CcSEcCtD
Triazolam—Loss of consciousness—Docetaxel—prostate cancer	9.53e-05	0.000611	CcSEcCtD
Triazolam—Dyspnoea—Etoposide—prostate cancer	9.49e-05	0.000608	CcSEcCtD
Triazolam—Malaise—Capecitabine—prostate cancer	9.47e-05	0.000607	CcSEcCtD
Triazolam—Somnolence—Etoposide—prostate cancer	9.46e-05	0.000607	CcSEcCtD
Triazolam—Hypersensitivity—Mitoxantrone—prostate cancer	9.43e-05	0.000604	CcSEcCtD
Triazolam—Syncope—Capecitabine—prostate cancer	9.41e-05	0.000603	CcSEcCtD
Triazolam—Diarrhoea—Estradiol—prostate cancer	9.4e-05	0.000602	CcSEcCtD
Triazolam—Hypertension—Docetaxel—prostate cancer	9.36e-05	0.0006	CcSEcCtD
Triazolam—Drowsiness—Epirubicin—prostate cancer	9.36e-05	0.0006	CcSEcCtD
Triazolam—Erythema—Prednisone—prostate cancer	9.35e-05	0.000599	CcSEcCtD
Triazolam—Palpitations—Capecitabine—prostate cancer	9.28e-05	0.000595	CcSEcCtD
Triazolam—Decreased appetite—Etoposide—prostate cancer	9.26e-05	0.000593	CcSEcCtD
Triazolam—Chest pain—Docetaxel—prostate cancer	9.23e-05	0.000592	CcSEcCtD
Triazolam—Loss of consciousness—Capecitabine—prostate cancer	9.23e-05	0.000591	CcSEcCtD
Triazolam—Asthenia—Mitoxantrone—prostate cancer	9.18e-05	0.000589	CcSEcCtD
Triazolam—Fatigue—Etoposide—prostate cancer	9.18e-05	0.000588	CcSEcCtD
Triazolam—Jaundice—Epirubicin—prostate cancer	9.12e-05	0.000585	CcSEcCtD
Triazolam—Stomatitis—Epirubicin—prostate cancer	9.12e-05	0.000585	CcSEcCtD
Triazolam—Pain—Etoposide—prostate cancer	9.1e-05	0.000584	CcSEcCtD
Triazolam—Constipation—Etoposide—prostate cancer	9.1e-05	0.000584	CcSEcCtD
Triazolam—Dizziness—Estradiol—prostate cancer	9.08e-05	0.000582	CcSEcCtD
Triazolam—Dysuria—Doxorubicin—prostate cancer	9.08e-05	0.000582	CcSEcCtD
Triazolam—Hypertension—Capecitabine—prostate cancer	9.06e-05	0.000581	CcSEcCtD
Triazolam—Dry mouth—Docetaxel—prostate cancer	9.03e-05	0.000579	CcSEcCtD
Triazolam—Chest pain—Capecitabine—prostate cancer	8.94e-05	0.000573	CcSEcCtD
Triazolam—Confusional state—Docetaxel—prostate cancer	8.92e-05	0.000572	CcSEcCtD
Triazolam—Anxiety—Capecitabine—prostate cancer	8.91e-05	0.000571	CcSEcCtD
Triazolam—Oedema—Docetaxel—prostate cancer	8.85e-05	0.000567	CcSEcCtD
Triazolam—Discomfort—Capecitabine—prostate cancer	8.83e-05	0.000566	CcSEcCtD
Triazolam—Clotiazepam—CYP2C19—prostate cancer	8.83e-05	0.0194	CrCbGaD
Triazolam—Feeling abnormal—Etoposide—prostate cancer	8.77e-05	0.000562	CcSEcCtD
Triazolam—Diarrhoea—Mitoxantrone—prostate cancer	8.76e-05	0.000561	CcSEcCtD
Triazolam—Dry mouth—Capecitabine—prostate cancer	8.74e-05	0.00056	CcSEcCtD
Triazolam—Vomiting—Estradiol—prostate cancer	8.73e-05	0.00056	CcSEcCtD
Triazolam—Oxazepam—CYP3A5—prostate cancer	8.72e-05	0.0192	CrCbGaD
Triazolam—Flurazepam—CYP2A6—prostate cancer	8.71e-05	0.0192	CrCbGaD
Triazolam—Gastrointestinal pain—Etoposide—prostate cancer	8.71e-05	0.000558	CcSEcCtD
Triazolam—Shock—Docetaxel—prostate cancer	8.71e-05	0.000558	CcSEcCtD
Triazolam—Ill-defined disorder—Prednisone—prostate cancer	8.68e-05	0.000556	CcSEcCtD
Triazolam—Drowsiness—Doxorubicin—prostate cancer	8.66e-05	0.000555	CcSEcCtD
Triazolam—Dermatitis—Estradiol—prostate cancer	8.65e-05	0.000555	CcSEcCtD
Triazolam—Confusional state—Capecitabine—prostate cancer	8.64e-05	0.000554	CcSEcCtD
Triazolam—Tachycardia—Docetaxel—prostate cancer	8.64e-05	0.000554	CcSEcCtD
Triazolam—Headache—Estradiol—prostate cancer	8.61e-05	0.000552	CcSEcCtD
Triazolam—Agitation—Prednisone—prostate cancer	8.59e-05	0.000551	CcSEcCtD
Triazolam—Oedema—Capecitabine—prostate cancer	8.57e-05	0.000549	CcSEcCtD
Triazolam—Jaundice—Doxorubicin—prostate cancer	8.44e-05	0.000541	CcSEcCtD
Triazolam—Stomatitis—Doxorubicin—prostate cancer	8.44e-05	0.000541	CcSEcCtD
Triazolam—Anorexia—Docetaxel—prostate cancer	8.43e-05	0.000541	CcSEcCtD
Triazolam—Malaise—Prednisone—prostate cancer	8.43e-05	0.00054	CcSEcCtD
Triazolam—Shock—Capecitabine—prostate cancer	8.43e-05	0.00054	CcSEcCtD
Triazolam—Abdominal pain—Etoposide—prostate cancer	8.42e-05	0.00054	CcSEcCtD
Triazolam—Syncope—Prednisone—prostate cancer	8.38e-05	0.000537	CcSEcCtD
Triazolam—Tachycardia—Capecitabine—prostate cancer	8.36e-05	0.000536	CcSEcCtD
Triazolam—Midazolam—CYP3A5—prostate cancer	8.35e-05	0.0184	CrCbGaD
Triazolam—Clobazam—CYP2C19—prostate cancer	8.34e-05	0.0183	CrCbGaD
Triazolam—Hyperhidrosis—Capecitabine—prostate cancer	8.28e-05	0.000531	CcSEcCtD
Triazolam—Loss of consciousness—Prednisone—prostate cancer	8.22e-05	0.000527	CcSEcCtD
Triazolam—Anorexia—Capecitabine—prostate cancer	8.17e-05	0.000523	CcSEcCtD
Triazolam—Nausea—Estradiol—prostate cancer	8.16e-05	0.000523	CcSEcCtD
Triazolam—Vomiting—Mitoxantrone—prostate cancer	8.14e-05	0.000522	CcSEcCtD
Triazolam—Visual impairment—Epirubicin—prostate cancer	8.1e-05	0.000519	CcSEcCtD
Triazolam—Quazepam—CYP2C19—prostate cancer	8.08e-05	0.0178	CrCbGaD
Triazolam—Hypertension—Prednisone—prostate cancer	8.07e-05	0.000517	CcSEcCtD
Triazolam—Dermatitis—Mitoxantrone—prostate cancer	8.06e-05	0.000517	CcSEcCtD
Triazolam—Headache—Mitoxantrone—prostate cancer	8.02e-05	0.000514	CcSEcCtD
Triazolam—Insomnia—Docetaxel—prostate cancer	8e-05	0.000513	CcSEcCtD
Triazolam—Paraesthesia—Docetaxel—prostate cancer	7.95e-05	0.000509	CcSEcCtD
Triazolam—Anxiety—Prednisone—prostate cancer	7.93e-05	0.000508	CcSEcCtD
Triazolam—Dyspnoea—Docetaxel—prostate cancer	7.89e-05	0.000506	CcSEcCtD
Triazolam—Somnolence—Docetaxel—prostate cancer	7.87e-05	0.000504	CcSEcCtD
Triazolam—Discomfort—Prednisone—prostate cancer	7.86e-05	0.000504	CcSEcCtD
Triazolam—Hypersensitivity—Etoposide—prostate cancer	7.84e-05	0.000503	CcSEcCtD
Triazolam—Tinnitus—Epirubicin—prostate cancer	7.83e-05	0.000502	CcSEcCtD
Triazolam—Insomnia—Capecitabine—prostate cancer	7.75e-05	0.000497	CcSEcCtD
Triazolam—Flunitrazepam—CYP2E1—prostate cancer	7.71e-05	0.017	CrCbGaD
Triazolam—Paraesthesia—Capecitabine—prostate cancer	7.69e-05	0.000493	CcSEcCtD
Triazolam—Decreased appetite—Docetaxel—prostate cancer	7.69e-05	0.000493	CcSEcCtD
Triazolam—Asthenia—Etoposide—prostate cancer	7.64e-05	0.00049	CcSEcCtD
Triazolam—Dyspnoea—Capecitabine—prostate cancer	7.64e-05	0.00049	CcSEcCtD
Triazolam—Flunitrazepam—CYP2C19—prostate cancer	7.63e-05	0.0168	CrCbGaD
Triazolam—Oedema—Prednisone—prostate cancer	7.63e-05	0.000489	CcSEcCtD
Triazolam—Fatigue—Docetaxel—prostate cancer	7.63e-05	0.000489	CcSEcCtD
Triazolam—Nausea—Mitoxantrone—prostate cancer	7.6e-05	0.000487	CcSEcCtD
Triazolam—Pain—Docetaxel—prostate cancer	7.57e-05	0.000485	CcSEcCtD
Triazolam—Constipation—Docetaxel—prostate cancer	7.57e-05	0.000485	CcSEcCtD
Triazolam—Pruritus—Etoposide—prostate cancer	7.53e-05	0.000483	CcSEcCtD
Triazolam—Shock—Prednisone—prostate cancer	7.51e-05	0.000481	CcSEcCtD
Triazolam—Visual impairment—Doxorubicin—prostate cancer	7.49e-05	0.00048	CcSEcCtD
Triazolam—Tachycardia—Prednisone—prostate cancer	7.45e-05	0.000477	CcSEcCtD
Triazolam—Decreased appetite—Capecitabine—prostate cancer	7.45e-05	0.000477	CcSEcCtD
Triazolam—Fatigue—Capecitabine—prostate cancer	7.39e-05	0.000473	CcSEcCtD
Triazolam—Hyperhidrosis—Prednisone—prostate cancer	7.38e-05	0.000473	CcSEcCtD
Triazolam—Constipation—Capecitabine—prostate cancer	7.33e-05	0.00047	CcSEcCtD
Triazolam—Pain—Capecitabine—prostate cancer	7.33e-05	0.00047	CcSEcCtD
Triazolam—Erythema—Epirubicin—prostate cancer	7.31e-05	0.000469	CcSEcCtD
Triazolam—Feeling abnormal—Docetaxel—prostate cancer	7.29e-05	0.000467	CcSEcCtD
Triazolam—Diarrhoea—Etoposide—prostate cancer	7.28e-05	0.000467	CcSEcCtD
Triazolam—Anorexia—Prednisone—prostate cancer	7.27e-05	0.000466	CcSEcCtD
Triazolam—Tinnitus—Doxorubicin—prostate cancer	7.25e-05	0.000465	CcSEcCtD
Triazolam—Gastrointestinal pain—Docetaxel—prostate cancer	7.24e-05	0.000464	CcSEcCtD
Triazolam—Flatulence—Epirubicin—prostate cancer	7.21e-05	0.000462	CcSEcCtD
Triazolam—Tension—Epirubicin—prostate cancer	7.18e-05	0.00046	CcSEcCtD
Triazolam—Dysgeusia—Epirubicin—prostate cancer	7.16e-05	0.000459	CcSEcCtD
Triazolam—Diazepam—CYP3A5—prostate cancer	7.15e-05	0.0157	CrCbGaD
Triazolam—Nervousness—Epirubicin—prostate cancer	7.1e-05	0.000455	CcSEcCtD
Triazolam—Feeling abnormal—Capecitabine—prostate cancer	7.06e-05	0.000453	CcSEcCtD
Triazolam—Dizziness—Etoposide—prostate cancer	7.04e-05	0.000451	CcSEcCtD
Triazolam—Muscle spasms—Epirubicin—prostate cancer	7.03e-05	0.000451	CcSEcCtD
Triazolam—Gastrointestinal pain—Capecitabine—prostate cancer	7.01e-05	0.000449	CcSEcCtD
Triazolam—Abdominal pain—Docetaxel—prostate cancer	6.99e-05	0.000448	CcSEcCtD
Triazolam—Insomnia—Prednisone—prostate cancer	6.9e-05	0.000442	CcSEcCtD
Triazolam—Paraesthesia—Prednisone—prostate cancer	6.85e-05	0.000439	CcSEcCtD
Triazolam—Adinazolam—CYP2C19—prostate cancer	6.8e-05	0.015	CrCbGaD
Triazolam—Ill-defined disorder—Epirubicin—prostate cancer	6.78e-05	0.000435	CcSEcCtD
Triazolam—Abdominal pain—Capecitabine—prostate cancer	6.77e-05	0.000434	CcSEcCtD
Triazolam—Vomiting—Etoposide—prostate cancer	6.77e-05	0.000434	CcSEcCtD
Triazolam—Erythema—Doxorubicin—prostate cancer	6.77e-05	0.000434	CcSEcCtD
Triazolam—Agitation—Epirubicin—prostate cancer	6.72e-05	0.000431	CcSEcCtD
Triazolam—Dermatitis—Etoposide—prostate cancer	6.71e-05	0.00043	CcSEcCtD
Triazolam—Headache—Etoposide—prostate cancer	6.67e-05	0.000428	CcSEcCtD
Triazolam—Flatulence—Doxorubicin—prostate cancer	6.67e-05	0.000427	CcSEcCtD
Triazolam—Tension—Doxorubicin—prostate cancer	6.64e-05	0.000426	CcSEcCtD
Triazolam—Decreased appetite—Prednisone—prostate cancer	6.63e-05	0.000425	CcSEcCtD
Triazolam—Dysgeusia—Doxorubicin—prostate cancer	6.63e-05	0.000425	CcSEcCtD
Triazolam—Malaise—Epirubicin—prostate cancer	6.59e-05	0.000423	CcSEcCtD
Triazolam—Fatigue—Prednisone—prostate cancer	6.58e-05	0.000422	CcSEcCtD
Triazolam—Nervousness—Doxorubicin—prostate cancer	6.57e-05	0.000421	CcSEcCtD
Triazolam—Syncope—Epirubicin—prostate cancer	6.56e-05	0.00042	CcSEcCtD
Triazolam—Constipation—Prednisone—prostate cancer	6.53e-05	0.000418	CcSEcCtD
Triazolam—Hypersensitivity—Docetaxel—prostate cancer	6.52e-05	0.000418	CcSEcCtD
Triazolam—Muscle spasms—Doxorubicin—prostate cancer	6.51e-05	0.000417	CcSEcCtD
Triazolam—Palpitations—Epirubicin—prostate cancer	6.46e-05	0.000414	CcSEcCtD
Triazolam—Loss of consciousness—Epirubicin—prostate cancer	6.43e-05	0.000412	CcSEcCtD
Triazolam—Asthenia—Docetaxel—prostate cancer	6.35e-05	0.000407	CcSEcCtD
Triazolam—Nausea—Etoposide—prostate cancer	6.32e-05	0.000405	CcSEcCtD
Triazolam—Hypertension—Epirubicin—prostate cancer	6.31e-05	0.000405	CcSEcCtD
Triazolam—Hypersensitivity—Capecitabine—prostate cancer	6.31e-05	0.000405	CcSEcCtD
Triazolam—Feeling abnormal—Prednisone—prostate cancer	6.29e-05	0.000403	CcSEcCtD
Triazolam—Ill-defined disorder—Doxorubicin—prostate cancer	6.28e-05	0.000402	CcSEcCtD
Triazolam—Chlordiazepoxide—CYP3A4—prostate cancer	6.26e-05	0.0138	CrCbGaD
Triazolam—Pruritus—Docetaxel—prostate cancer	6.26e-05	0.000401	CcSEcCtD
Triazolam—Gastrointestinal pain—Prednisone—prostate cancer	6.24e-05	0.0004	CcSEcCtD
Triazolam—Chest pain—Epirubicin—prostate cancer	6.23e-05	0.000399	CcSEcCtD
Triazolam—Agitation—Doxorubicin—prostate cancer	6.22e-05	0.000399	CcSEcCtD
Triazolam—Anxiety—Epirubicin—prostate cancer	6.2e-05	0.000398	CcSEcCtD
Triazolam—Flurazepam—CYP2E1—prostate cancer	6.19e-05	0.0136	CrCbGaD
Triazolam—Discomfort—Epirubicin—prostate cancer	6.15e-05	0.000394	CcSEcCtD
Triazolam—Asthenia—Capecitabine—prostate cancer	6.15e-05	0.000394	CcSEcCtD
Triazolam—Malaise—Doxorubicin—prostate cancer	6.1e-05	0.000391	CcSEcCtD
Triazolam—Dry mouth—Epirubicin—prostate cancer	6.09e-05	0.00039	CcSEcCtD
Triazolam—Syncope—Doxorubicin—prostate cancer	6.07e-05	0.000389	CcSEcCtD
Triazolam—Pruritus—Capecitabine—prostate cancer	6.06e-05	0.000389	CcSEcCtD
Triazolam—Diarrhoea—Docetaxel—prostate cancer	6.05e-05	0.000388	CcSEcCtD
Triazolam—Clonazepam—CYP3A4—prostate cancer	6.05e-05	0.0133	CrCbGaD
Triazolam—Abdominal pain—Prednisone—prostate cancer	6.03e-05	0.000387	CcSEcCtD
Triazolam—Confusional state—Epirubicin—prostate cancer	6.02e-05	0.000386	CcSEcCtD
Triazolam—Palpitations—Doxorubicin—prostate cancer	5.98e-05	0.000383	CcSEcCtD
Triazolam—Oedema—Epirubicin—prostate cancer	5.97e-05	0.000383	CcSEcCtD
Triazolam—Loss of consciousness—Doxorubicin—prostate cancer	5.95e-05	0.000381	CcSEcCtD
Triazolam—Shock—Epirubicin—prostate cancer	5.87e-05	0.000376	CcSEcCtD
Triazolam—Diarrhoea—Capecitabine—prostate cancer	5.86e-05	0.000376	CcSEcCtD
Triazolam—Temazepam—CYP2C19—prostate cancer	5.86e-05	0.0129	CrCbGaD
Triazolam—Dizziness—Docetaxel—prostate cancer	5.85e-05	0.000375	CcSEcCtD
Triazolam—Hypertension—Doxorubicin—prostate cancer	5.84e-05	0.000374	CcSEcCtD
Triazolam—Tachycardia—Epirubicin—prostate cancer	5.82e-05	0.000373	CcSEcCtD
Triazolam—Hyperhidrosis—Epirubicin—prostate cancer	5.77e-05	0.00037	CcSEcCtD
Triazolam—Chest pain—Doxorubicin—prostate cancer	5.76e-05	0.000369	CcSEcCtD
Triazolam—Anxiety—Doxorubicin—prostate cancer	5.74e-05	0.000368	CcSEcCtD
Triazolam—Midazolam—CYP2E1—prostate cancer	5.74e-05	0.0126	CrCbGaD
Triazolam—Discomfort—Doxorubicin—prostate cancer	5.69e-05	0.000365	CcSEcCtD
Triazolam—Anorexia—Epirubicin—prostate cancer	5.69e-05	0.000365	CcSEcCtD
Triazolam—Dizziness—Capecitabine—prostate cancer	5.66e-05	0.000363	CcSEcCtD
Triazolam—Dry mouth—Doxorubicin—prostate cancer	5.63e-05	0.000361	CcSEcCtD
Triazolam—Vomiting—Docetaxel—prostate cancer	5.63e-05	0.000361	CcSEcCtD
Triazolam—Hypersensitivity—Prednisone—prostate cancer	5.62e-05	0.00036	CcSEcCtD
Triazolam—Clotiazepam—CYP3A4—prostate cancer	5.61e-05	0.0124	CrCbGaD
Triazolam—Dermatitis—Docetaxel—prostate cancer	5.57e-05	0.000357	CcSEcCtD
Triazolam—Confusional state—Doxorubicin—prostate cancer	5.57e-05	0.000357	CcSEcCtD
Triazolam—Headache—Docetaxel—prostate cancer	5.54e-05	0.000355	CcSEcCtD
Triazolam—Oedema—Doxorubicin—prostate cancer	5.52e-05	0.000354	CcSEcCtD
Triazolam—Asthenia—Prednisone—prostate cancer	5.47e-05	0.000351	CcSEcCtD
Triazolam—Vomiting—Capecitabine—prostate cancer	5.45e-05	0.000349	CcSEcCtD
Triazolam—Shock—Doxorubicin—prostate cancer	5.43e-05	0.000348	CcSEcCtD
Triazolam—Pruritus—Prednisone—prostate cancer	5.4e-05	0.000346	CcSEcCtD
Triazolam—Insomnia—Epirubicin—prostate cancer	5.4e-05	0.000346	CcSEcCtD
Triazolam—Dermatitis—Capecitabine—prostate cancer	5.4e-05	0.000346	CcSEcCtD
Triazolam—Tachycardia—Doxorubicin—prostate cancer	5.39e-05	0.000345	CcSEcCtD
Triazolam—Headache—Capecitabine—prostate cancer	5.37e-05	0.000344	CcSEcCtD
Triazolam—Paraesthesia—Epirubicin—prostate cancer	5.36e-05	0.000344	CcSEcCtD
Triazolam—Hyperhidrosis—Doxorubicin—prostate cancer	5.34e-05	0.000342	CcSEcCtD
Triazolam—Dyspnoea—Epirubicin—prostate cancer	5.32e-05	0.000341	CcSEcCtD
Triazolam—Somnolence—Epirubicin—prostate cancer	5.31e-05	0.00034	CcSEcCtD
Triazolam—Alprazolam—CYP3A4—prostate cancer	5.3e-05	0.0117	CrCbGaD
Triazolam—Clobazam—CYP3A4—prostate cancer	5.3e-05	0.0117	CrCbGaD
Triazolam—Anorexia—Doxorubicin—prostate cancer	5.26e-05	0.000337	CcSEcCtD
Triazolam—Nausea—Docetaxel—prostate cancer	5.26e-05	0.000337	CcSEcCtD
Triazolam—Diarrhoea—Prednisone—prostate cancer	5.22e-05	0.000335	CcSEcCtD
Triazolam—Decreased appetite—Epirubicin—prostate cancer	5.19e-05	0.000333	CcSEcCtD
Triazolam—Fatigue—Epirubicin—prostate cancer	5.15e-05	0.00033	CcSEcCtD
Triazolam—Quazepam—CYP3A4—prostate cancer	5.14e-05	0.0113	CrCbGaD
Triazolam—Constipation—Epirubicin—prostate cancer	5.1e-05	0.000327	CcSEcCtD
Triazolam—Pain—Epirubicin—prostate cancer	5.1e-05	0.000327	CcSEcCtD
Triazolam—Nausea—Capecitabine—prostate cancer	5.09e-05	0.000326	CcSEcCtD
Triazolam—Dizziness—Prednisone—prostate cancer	5.05e-05	0.000323	CcSEcCtD
Triazolam—Insomnia—Doxorubicin—prostate cancer	4.99e-05	0.00032	CcSEcCtD
Triazolam—Paraesthesia—Doxorubicin—prostate cancer	4.96e-05	0.000318	CcSEcCtD
Triazolam—Dyspnoea—Doxorubicin—prostate cancer	4.92e-05	0.000316	CcSEcCtD
Triazolam—Feeling abnormal—Epirubicin—prostate cancer	4.92e-05	0.000315	CcSEcCtD
Triazolam—Diazepam—CYP2E1—prostate cancer	4.91e-05	0.0108	CrCbGaD
Triazolam—Somnolence—Doxorubicin—prostate cancer	4.91e-05	0.000315	CcSEcCtD
Triazolam—Gastrointestinal pain—Epirubicin—prostate cancer	4.88e-05	0.000313	CcSEcCtD
Triazolam—Diazepam—CYP2C19—prostate cancer	4.87e-05	0.0107	CrCbGaD
Triazolam—Flunitrazepam—CYP3A4—prostate cancer	4.85e-05	0.0107	CrCbGaD
Triazolam—Vomiting—Prednisone—prostate cancer	4.85e-05	0.000311	CcSEcCtD
Triazolam—Dermatitis—Prednisone—prostate cancer	4.81e-05	0.000308	CcSEcCtD
Triazolam—Decreased appetite—Doxorubicin—prostate cancer	4.8e-05	0.000308	CcSEcCtD
Triazolam—Headache—Prednisone—prostate cancer	4.78e-05	0.000306	CcSEcCtD
Triazolam—Fatigue—Doxorubicin—prostate cancer	4.76e-05	0.000305	CcSEcCtD
Triazolam—Constipation—Doxorubicin—prostate cancer	4.72e-05	0.000303	CcSEcCtD
Triazolam—Pain—Doxorubicin—prostate cancer	4.72e-05	0.000303	CcSEcCtD
Triazolam—Abdominal pain—Epirubicin—prostate cancer	4.72e-05	0.000302	CcSEcCtD
Triazolam—Feeling abnormal—Doxorubicin—prostate cancer	4.55e-05	0.000292	CcSEcCtD
Triazolam—Estazolam—CYP3A4—prostate cancer	4.54e-05	0.00999	CrCbGaD
Triazolam—Nausea—Prednisone—prostate cancer	4.53e-05	0.000291	CcSEcCtD
Triazolam—Gastrointestinal pain—Doxorubicin—prostate cancer	4.52e-05	0.000289	CcSEcCtD
Triazolam—Hypersensitivity—Epirubicin—prostate cancer	4.4e-05	0.000282	CcSEcCtD
Triazolam—Abdominal pain—Doxorubicin—prostate cancer	4.37e-05	0.00028	CcSEcCtD
Triazolam—Adinazolam—CYP3A4—prostate cancer	4.32e-05	0.00951	CrCbGaD
Triazolam—Asthenia—Epirubicin—prostate cancer	4.28e-05	0.000274	CcSEcCtD
Triazolam—Pruritus—Epirubicin—prostate cancer	4.22e-05	0.000271	CcSEcCtD
Triazolam—Prazepam—CYP3A4—prostate cancer	4.18e-05	0.00919	CrCbGaD
Triazolam—Diarrhoea—Epirubicin—prostate cancer	4.08e-05	0.000262	CcSEcCtD
Triazolam—Hypersensitivity—Doxorubicin—prostate cancer	4.07e-05	0.000261	CcSEcCtD
Triazolam—Asthenia—Doxorubicin—prostate cancer	3.96e-05	0.000254	CcSEcCtD
Triazolam—Dizziness—Epirubicin—prostate cancer	3.95e-05	0.000253	CcSEcCtD
Triazolam—Pruritus—Doxorubicin—prostate cancer	3.91e-05	0.00025	CcSEcCtD
Triazolam—Flurazepam—CYP3A4—prostate cancer	3.9e-05	0.00857	CrCbGaD
Triazolam—Vomiting—Epirubicin—prostate cancer	3.79e-05	0.000243	CcSEcCtD
Triazolam—Diarrhoea—Doxorubicin—prostate cancer	3.78e-05	0.000242	CcSEcCtD
Triazolam—Oxazepam—CYP3A4—prostate cancer	3.77e-05	0.0083	CrCbGaD
Triazolam—Dermatitis—Epirubicin—prostate cancer	3.76e-05	0.000241	CcSEcCtD
Triazolam—Headache—Epirubicin—prostate cancer	3.74e-05	0.00024	CcSEcCtD
Triazolam—Temazepam—CYP3A4—prostate cancer	3.73e-05	0.0082	CrCbGaD
Triazolam—Dizziness—Doxorubicin—prostate cancer	3.65e-05	0.000234	CcSEcCtD
Triazolam—Midazolam—CYP3A4—prostate cancer	3.61e-05	0.00795	CrCbGaD
Triazolam—Nausea—Epirubicin—prostate cancer	3.54e-05	0.000227	CcSEcCtD
Triazolam—Vomiting—Doxorubicin—prostate cancer	3.51e-05	0.000225	CcSEcCtD
Triazolam—Dermatitis—Doxorubicin—prostate cancer	3.48e-05	0.000223	CcSEcCtD
Triazolam—Headache—Doxorubicin—prostate cancer	3.46e-05	0.000222	CcSEcCtD
Triazolam—Nausea—Doxorubicin—prostate cancer	3.28e-05	0.00021	CcSEcCtD
Triazolam—Diazepam—CYP3A4—prostate cancer	3.1e-05	0.00681	CrCbGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	4.85e-06	5.21e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTA2—prostate cancer	4.84e-06	5.2e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP17A1—prostate cancer	4.81e-06	5.16e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ITPR1—prostate cancer	4.79e-06	5.15e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SULT1A1—prostate cancer	4.78e-06	5.14e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCG5—prostate cancer	4.78e-06	5.14e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NCOA3—prostate cancer	4.75e-06	5.11e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HPGD—prostate cancer	4.73e-06	5.08e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—B4GALT4—prostate cancer	4.73e-06	5.08e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.67e-06	5.02e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTA1—prostate cancer	4.67e-06	5.02e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTO1—prostate cancer	4.62e-06	4.96e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HSD3B2—prostate cancer	4.62e-06	4.96e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NAT2—prostate cancer	4.62e-06	4.96e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NCOA2—prostate cancer	4.58e-06	4.92e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HPGDS—prostate cancer	4.54e-06	4.87e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—TYMS—prostate cancer	4.53e-06	4.86e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2C19—prostate cancer	4.51e-06	4.84e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTM1—prostate cancer	4.48e-06	4.81e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TNFRSF21—prostate cancer	4.44e-06	4.77e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	4.44e-06	4.77e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LRP2—prostate cancer	4.43e-06	4.75e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PLCB2—prostate cancer	4.43e-06	4.75e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2C18—prostate cancer	4.43e-06	4.75e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ACHE—prostate cancer	4.4e-06	4.72e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTT1—prostate cancer	4.4e-06	4.72e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—LPL—prostate cancer	4.39e-06	4.72e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SLC5A5—prostate cancer	4.37e-06	4.69e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2A6—prostate cancer	4.35e-06	4.67e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—P4HB—prostate cancer	4.34e-06	4.66e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.33e-06	4.65e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP7B1—prostate cancer	4.32e-06	4.64e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MTAP—prostate cancer	4.32e-06	4.64e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP2E1—prostate cancer	4.27e-06	4.58e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP1A1—prostate cancer	4.24e-06	4.56e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AKR1C3—prostate cancer	4.23e-06	4.54e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC22A1—prostate cancer	4.22e-06	4.54e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NQO1—prostate cancer	4.22e-06	4.53e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SULT1E1—prostate cancer	4.21e-06	4.52e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SRD5A1—prostate cancer	4.21e-06	4.52e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ERCC2—prostate cancer	4.21e-06	4.52e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PRKACB—prostate cancer	4.21e-06	4.52e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	4.17e-06	4.48e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP17A1—prostate cancer	4.16e-06	4.47e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TH—prostate cancer	4.16e-06	4.47e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP3A4—prostate cancer	4.12e-06	4.42e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SULT2A1—prostate cancer	4.12e-06	4.42e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	4.11e-06	4.41e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MED12—prostate cancer	4.05e-06	4.35e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP1B1—prostate cancer	4.05e-06	4.35e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HSD17B3—prostate cancer	4.02e-06	4.32e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ACSL4—prostate cancer	4.02e-06	4.32e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GNG5—prostate cancer	4.02e-06	4.31e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NCOA2—prostate cancer	3.97e-06	4.26e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MTHFR—prostate cancer	3.96e-06	4.25e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GGT1—prostate cancer	3.92e-06	4.21e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPARA—prostate cancer	3.88e-06	4.17e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NCOA3—prostate cancer	3.87e-06	4.16e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NCOA1—prostate cancer	3.86e-06	4.15e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—UMPS—prostate cancer	3.85e-06	4.14e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PHGDH—prostate cancer	3.85e-06	4.14e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ARG2—prostate cancer	3.85e-06	4.14e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP19A1—prostate cancer	3.8e-06	4.09e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.8e-06	4.08e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SLC5A5—prostate cancer	3.79e-06	4.07e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LDHB—prostate cancer	3.78e-06	4.06e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP3A5—prostate cancer	3.71e-06	3.98e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2E1—prostate cancer	3.7e-06	3.97e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HPGDS—prostate cancer	3.69e-06	3.96e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—RXRA—prostate cancer	3.67e-06	3.94e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2C19—prostate cancer	3.67e-06	3.94e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NQO1—prostate cancer	3.66e-06	3.93e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CAV1—prostate cancer	3.65e-06	3.92e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TH—prostate cancer	3.6e-06	3.87e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PDHA1—prostate cancer	3.58e-06	3.85e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TCN2—prostate cancer	3.58e-06	3.85e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—UCP3—prostate cancer	3.58e-06	3.85e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA3—prostate cancer	3.58e-06	3.85e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ACHE—prostate cancer	3.58e-06	3.85e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTT1—prostate cancer	3.58e-06	3.85e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.58e-06	3.84e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP3A4—prostate cancer	3.57e-06	3.83e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.55e-06	3.81e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2A6—prostate cancer	3.54e-06	3.8e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—COMT—prostate cancer	3.54e-06	3.8e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.53e-06	3.79e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTP1—prostate cancer	3.52e-06	3.78e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP1B1—prostate cancer	3.51e-06	3.76e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ITPR1—prostate cancer	3.46e-06	3.72e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AKR1C3—prostate cancer	3.44e-06	3.7e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PRKACB—prostate cancer	3.42e-06	3.68e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC22A3—prostate cancer	3.42e-06	3.67e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HSD3B1—prostate cancer	3.42e-06	3.67e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GGT1—prostate cancer	3.39e-06	3.65e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP17A1—prostate cancer	3.39e-06	3.64e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NCOA1—prostate cancer	3.34e-06	3.59e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.34e-06	3.59e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CG—prostate cancer	3.32e-06	3.57e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP19A1—prostate cancer	3.3e-06	3.54e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TBXAS1—prostate cancer	3.28e-06	3.52e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA4—prostate cancer	3.28e-06	3.52e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TYMS—prostate cancer	3.27e-06	3.52e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTM1—prostate cancer	3.24e-06	3.47e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NCOA2—prostate cancer	3.23e-06	3.47e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA2—prostate cancer	3.19e-06	3.43e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—RXRA—prostate cancer	3.18e-06	3.42e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—LPL—prostate cancer	3.18e-06	3.41e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCG5—prostate cancer	3.15e-06	3.39e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SULT1A1—prostate cancer	3.15e-06	3.39e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—INS—prostate cancer	3.15e-06	3.38e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.09e-06	3.32e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CREBBP—prostate cancer	3.08e-06	3.31e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SLC5A5—prostate cancer	3.08e-06	3.31e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA1—prostate cancer	3.08e-06	3.31e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP1A1—prostate cancer	3.07e-06	3.29e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—COMT—prostate cancer	3.06e-06	3.29e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTP1—prostate cancer	3.05e-06	3.28e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HSD3B2—prostate cancer	3.05e-06	3.27e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTO1—prostate cancer	3.05e-06	3.27e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NAT2—prostate cancer	3.05e-06	3.27e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ERCC2—prostate cancer	3.04e-06	3.27e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2E1—prostate cancer	3.01e-06	3.23e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ITPR1—prostate cancer	3e-06	3.22e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NQO1—prostate cancer	2.98e-06	3.2e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.95e-06	3.17e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TH—prostate cancer	2.93e-06	3.15e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CD—prostate cancer	2.92e-06	3.14e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLCB2—prostate cancer	2.92e-06	3.14e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.92e-06	3.14e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LRP2—prostate cancer	2.92e-06	3.14e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.91e-06	3.13e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.9e-06	3.12e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.89e-06	3.1e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—P4HB—prostate cancer	2.86e-06	3.08e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MTHFR—prostate cancer	2.86e-06	3.07e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.85e-06	3.06e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TYMS—prostate cancer	2.83e-06	3.04e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPARA—prostate cancer	2.8e-06	3.01e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTM1—prostate cancer	2.8e-06	3.01e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.79e-06	2.99e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GGT1—prostate cancer	2.76e-06	2.97e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NOS3—prostate cancer	2.76e-06	2.96e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—LPL—prostate cancer	2.75e-06	2.95e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NCOA1—prostate cancer	2.72e-06	2.92e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.71e-06	2.92e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.68e-06	2.88e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MED12—prostate cancer	2.67e-06	2.87e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP1A1—prostate cancer	2.66e-06	2.85e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GNG5—prostate cancer	2.65e-06	2.85e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CAV1—prostate cancer	2.64e-06	2.83e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ERCC2—prostate cancer	2.63e-06	2.83e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—RXRA—prostate cancer	2.59e-06	2.78e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NCOA3—prostate cancer	2.55e-06	2.74e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CB—prostate cancer	2.55e-06	2.73e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS2—prostate cancer	2.52e-06	2.71e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.52e-06	2.7e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—COMT—prostate cancer	2.49e-06	2.68e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTP1—prostate cancer	2.48e-06	2.67e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MTHFR—prostate cancer	2.48e-06	2.66e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ITPR1—prostate cancer	2.44e-06	2.62e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HPGDS—prostate cancer	2.43e-06	2.61e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPARA—prostate cancer	2.43e-06	2.61e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.42e-06	2.6e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CG—prostate cancer	2.4e-06	2.58e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.4e-06	2.58e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ACHE—prostate cancer	2.36e-06	2.54e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTT1—prostate cancer	2.36e-06	2.54e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.33e-06	2.51e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TYMS—prostate cancer	2.31e-06	2.48e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CAV1—prostate cancer	2.28e-06	2.45e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTM1—prostate cancer	2.28e-06	2.45e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—INS—prostate cancer	2.27e-06	2.44e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.27e-06	2.44e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PRKACB—prostate cancer	2.26e-06	2.43e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—LPL—prostate cancer	2.24e-06	2.4e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.24e-06	2.4e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CREBBP—prostate cancer	2.23e-06	2.39e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTEN—prostate cancer	2.2e-06	2.36e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.18e-06	2.34e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.16e-06	2.32e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ERCC2—prostate cancer	2.14e-06	2.3e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NCOA2—prostate cancer	2.13e-06	2.29e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CD—prostate cancer	2.11e-06	2.27e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—EP300—prostate cancer	2.1e-06	2.25e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CG—prostate cancer	2.08e-06	2.23e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.03e-06	2.18e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MTHFR—prostate cancer	2.02e-06	2.16e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NOS3—prostate cancer	1.99e-06	2.14e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.98e-06	2.13e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPARA—prostate cancer	1.98e-06	2.12e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—INS—prostate cancer	1.97e-06	2.12e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NQO1—prostate cancer	1.96e-06	2.11e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TH—prostate cancer	1.93e-06	2.08e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CREBBP—prostate cancer	1.93e-06	2.07e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.88e-06	2.02e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CAV1—prostate cancer	1.86e-06	2e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.84e-06	1.98e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.83e-06	1.96e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS2—prostate cancer	1.82e-06	1.96e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GGT1—prostate cancer	1.82e-06	1.96e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NCOA1—prostate cancer	1.79e-06	1.93e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.78e-06	1.91e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.77e-06	1.9e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NOS3—prostate cancer	1.73e-06	1.86e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—RXRA—prostate cancer	1.71e-06	1.83e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.69e-06	1.82e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—COMT—prostate cancer	1.64e-06	1.77e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTP1—prostate cancer	1.64e-06	1.76e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ITPR1—prostate cancer	1.61e-06	1.73e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—INS—prostate cancer	1.6e-06	1.72e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.59e-06	1.71e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTEN—prostate cancer	1.59e-06	1.71e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS2—prostate cancer	1.58e-06	1.7e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CREBBP—prostate cancer	1.57e-06	1.69e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CA—prostate cancer	1.55e-06	1.67e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TYMS—prostate cancer	1.52e-06	1.63e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—EP300—prostate cancer	1.52e-06	1.63e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTM1—prostate cancer	1.5e-06	1.62e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.49e-06	1.6e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—LPL—prostate cancer	1.48e-06	1.59e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.43e-06	1.53e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ERCC2—prostate cancer	1.41e-06	1.52e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NOS3—prostate cancer	1.41e-06	1.51e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTEN—prostate cancer	1.38e-06	1.48e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MTHFR—prostate cancer	1.33e-06	1.43e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—EP300—prostate cancer	1.31e-06	1.41e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPARA—prostate cancer	1.3e-06	1.4e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.3e-06	1.39e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS2—prostate cancer	1.29e-06	1.38e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—AKT1—prostate cancer	1.27e-06	1.36e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CAV1—prostate cancer	1.23e-06	1.32e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.12e-06	1.21e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTEN—prostate cancer	1.12e-06	1.2e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.12e-06	1.2e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—EP300—prostate cancer	1.07e-06	1.15e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—INS—prostate cancer	1.06e-06	1.14e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CREBBP—prostate cancer	1.04e-06	1.11e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CD—prostate cancer	9.82e-07	1.05e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CA—prostate cancer	9.72e-07	1.04e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NOS3—prostate cancer	9.27e-07	9.96e-06	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—AKT1—prostate cancer	9.17e-07	9.85e-06	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CB—prostate cancer	8.56e-07	9.19e-06	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS2—prostate cancer	8.48e-07	9.11e-06	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AKT1—prostate cancer	7.94e-07	8.53e-06	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CA—prostate cancer	7.91e-07	8.5e-06	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTEN—prostate cancer	7.39e-07	7.94e-06	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—EP300—prostate cancer	7.05e-07	7.57e-06	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AKT1—prostate cancer	6.46e-07	6.94e-06	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.22e-07	5.6e-06	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AKT1—prostate cancer	4.26e-07	4.58e-06	CbGpPWpGaD
